NCT05873686 2026-03-03A Phase 1 Clinical Study of NXP900 in Subjects With Advanced CancersNuvectis Pharma, Inc.Phase 1 Recruiting140 enrolled
NCT05795595 2025-11-26A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid TumorsCRISPR TherapeuticsPhase 1/2 Completed19 enrolled
NCT04985357 2024-11-25Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsTravera IncWithdrawn
NCT05498597 2023-10-19AMT-151 in Patients With Selected Advanced Solid TumoursMultitude Therapeutics Inc.Phase 1 Unknown30 enrolled